Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Laureate Pharma | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Laureate Pharma

Kathleen P. Bloch has been appointed chief financial officer of Laureate Pharma.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Kathleen P. Bloch has been appointed chief financial officer of Laureate Pharma. Ms. Bloch is responsible for finance, accounting and IT activities in addition to serving as a member of the company’s management committee. Her primary objective is to increase capital and provide a platform for the continued growth of the company. Her plans include the development of interactive financial reporting systems, including a project-facing system and a materials management system aimed at enhancing client relationships.

“Kathy brings more than 20 years executive financial experience to Laureate and she has managed growth and driven performance in rapidly-expanding manufacturing environments,” said Michael A. Griffith, chief executive officer of Laureate. “She possesses the knowledge and expertise required to lead Laureate Pharma as we invest and grow.”

Ms. Bloch joins the company from PC Group, Inc., where she served as chief operating officer and chief financial officer since 2007. Prior to this, Ms. Bloch managed day-to-day operations for The Silverman Group, a real estate and investment company.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters